Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Global Microfluidics Devices Market" report has been added to ResearchAndMarkets.com's offering.
The global microfluidics devices market is undergoing a rapid transformation with an anticipated market value surge from USD 32.76 billion in 2023 to an impressive USD 305.65 billion by 2034. An exemplar of innovation and advanced technological integration, the industry's exponential growth, marked by a CAGR of 22.51% over the forecast period from 2024 to 2034, is reflective of the increasing demand for point-of-care diagnostics and personalized medicine.
Market researchers have unveiled a detailed, comprehensive report that shines a spotlight on the pivotal advancements and burgeoning demand across the microfluidics landscape. As healthcare and biotechnological applications continue to evolve, this sector's remarkable upsurge in hospital and diagnostic centers propels it to the highest revenue-contributing segment in 2023.
Segment Analysis and Regional Insights
Within the market, microfluidic-based devices have emerged as industry frontrunners due to their efficacious deployment across diverse sectors, particularly healthcare. Simultaneously, an uptick in microfluidic component utilization forecasts a robust growth trajectory. The in-depth analysis extends to dissect key application areas, such as in-vitro diagnostics, pharmaceutical and life science research and manufacturing, stressing the indispensable role of microfluidics in fostering industry revolutionization.
The report delineates end-user categorizations, emphasizing the surge in microfluidics implementation within hospitals and diagnostic centers, and forecasts a rising demand from pharmaceutical and biotechnology companies due to escalated development in drugs and personalized treatments.
Navigating through the Regional Markets
In an insightful regional analysis, North America's standing as the market leader is attributed to robust R&D investments and highly developed healthcare infrastructure. Nevertheless, the Asia Pacific region is not one to overlook, as it is conjectured to achieve the most rapid CAGR throughout the forecast period, spurred by burgeoning research initiatives and healthcare advancements.
- North America: Dominant market share with sustained growth.
- Asia-Pacific: Fastest-growing region, championed by research escalations and healthcare sector investments.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023-2034 |
| Estimated Market Value (USD) in 2023 | $32.76 Billion |
| Forecasted Market Value (USD) by 2034 | $305.65 Billion |
| Compound Annual Growth Rate | 22.5% |
| Regions Covered | Global |
Companies Mentioned
- Hologic Inc.
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Fujifilm Holdings Corporation
- Carestream Health
- Planmed Oy
- IMS Srl
- Metaltronica S.p.A.
- Agfa-Gevaert Group
- General Medical Merate S.p.A.
- Konica Minolta Inc.
- Delphinus Medical Technologies Inc.
- ADANI Systems Inc.
- Allengers Medical Systems Limited.
For more information about this report visit https://www.researchandmarkets.com/r/8j24ex
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
